Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-028080

President & CEO acquired 127,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-19 Grant or award : show line 1 in the form +127,500 1,015,230 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-19 Grant or award : show line 2 in the form Emp. Stock Option (Right to Buy) +595,000 595,000 D
Loading xslF345X03/form4.xml…